Core--Pilot project program

试点项目计划旨在促进新的领域， 跨研究核心学科的研究和合作。最终 目的是让中心内的研究人员获得初步数据， 为NIH/NIEHS或其他资助机构准备更大的资助申请。 新的RFA试点项目将指导感兴趣领域的研究， 已确定为该中心的未来重点。将在哪些领域 目标是使用简单的生物体，如酵母，以了解机制 扩大基因芯片技术在化学毒性研究中的应用 化学致癌机制、吸入毒性和分子 流行病学;并制定方法，以确定谁是最 暴露于环境污染，并识别那些 最容易受到环境毒素和致癌物质的伤害。 长期目标是增加赠款组合。 在上一个供资期间，资金用于协助开发 新的调查员，并支持新的举措， investigators.中心政策改变，资金将用于支持 纽约大学医学院的新调查员其中50%的 资金将用于资助中心感兴趣的RFAs， 试点项目资金的50%将用于资助者发起的项目。 所有这些资金将通过竞争向纽约大学的所有教职员工开放。 试点项目赠款是10页的NIH格式，并在20000美元授予 每一个一年。每个项目选择四名评审员，他们是 要求准备一份书面评论。唐文雄医生会处理的 程序. Tang，Costa，所罗门博士和内部和外部顾问 各委员会将制定RFA并作出供资决定， 科学同行评审

The Pilot Project Program is designed to promote new areas of research and collaboration across Research Core disciplines. The ultimate purpose is for investigators within the Center to obtain preliminary data to prepare a larger grant application for NIH/NIEHS or other funding agencies. The new RFA pilot projects will direct research in areas of interest that have been identified for the future emphasis for the Center. The areas to be targeted are use of simple organisms, such as yeast, to understand mechanisms of chemical toxicity; expand the use of Gene Chip Technology in studying mechanisms of chemical carcinogenesis, inhalation toxicity, and molecular epidemiology; and to develop methods to identify individuals who are most exposed to environmental contamination and to identify those individuals who are the most susceptible to injury by environmental toxins and carcinogens. The long-term goal is to increase the portfolio of grants. During the previous funding period funds were use to assist in the development of new investigators and to support new initiatives by established investigators. Center policy has changed and funds will be use to support new investigators from the NYU School of Medicine. Fifty percent of these monies will be used to fund RFAs of interest to the Center and the remaining 50% of Pilot Project funds will be used on investigator-initiated projects. All these funds will be open to all faculty members at NYU by competition. Pilot project grants are 10 pages in an NIH format, and awarded at $20,000 each for one year. Four reviewers are chosen for each project, and they are asked to prepare a written critique. Dr. Moon-Shong Tang will manage this program. Drs. Tang, Costa, Solomon, and the Internal and External Advisory Committees will formulate the RFAs and make funding decisions following scientific peer-review.